Valuation : Genix Pharmaceuticals Corporation

Market Cap 1.22M 881K 759K 712K 650K 84.23M 1.23M 8.45M 3.3M 42.52M 3.31M 3.24M 141M P/E 2024
-40.5x
P/E 2025 -5.33x
Enterprise Value 2.22M 1.6M 1.38M 1.29M 1.18M 153M 2.23M 15.34M 5.99M 77.22M 6.01M 5.88M 256M EV / Sales 2024
929,496,174x
EV / Sales 2025 -
Free-Float
53.08%
Yield 2024 *
-
Yield 2025 -
Current month+33.33%
1 month+33.33%
3 months+33.33%
Current year-20.00%
1 week 0.02
Extreme 0.02
0.02
1 month 0.02
Extreme 0.02
0.02
Current year 0.02
Extreme 0.015
0.02
1 year 0.02
Extreme 0.015
0.04
3 years 0.02
Extreme 0.015
0.09
5 years 0.02
Extreme 0.015
0.19
10 years 0.01
Extreme 0.01
0.3
Manager TitleAgeSince
Chief Executive Officer 57 03/08/2018
Director of Finance/CFO - 04/05/2026
President - 21/05/2021
Director TitleAgeSince
Director/Board Member 57 03/08/2018
Director/Board Member 76 11/03/2019
Director/Board Member 44 05/09/2019
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/25 Option

Chairman

1,000,000 1.6885%
09/09/25 Option

Chairman

1,000,000 1.6885%
09/09/25 Option

Chief Executive Officer

1,000,000 1.6885%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-33.33%-66.67% 881K
+3.38%+3.92%+26.96%+78.55% 48.2B
+0.66%+0.45%+57.74%+122.48% 39.97B
-2.49%+5.21%+17.18%+85.56% 12.43B
-1.00%-2.00%-11.21%+12.05% 12.03B
+0.19%0.00%+29.35%+150.00% 9.35B
-0.07%-1.80%+25.02%+48.33% 7.75B
-1.39%+3.74%+28.71%+223.40% 7.43B
-0.26%+0.10%+47.89%-11.58% 7.22B
-0.53%-1.53%-36.09%+17.02% 5.3B
Average -0.35%+2.17%+15.22%+65.91% 14.97B
Weighted average by Cap. +0.78%+1.79%+30.21%+89.08%

Financials

2024 2025
Net sales 0 0 0 0 0 0.28 0 0.03 0.01 0.14 0.01 0.01 0.47 -
Net income -73.2K -52.68K -45.4K -42.56K -38.85K -5.04M -73.43K -505K -197K -2.54M -198K -193K -8.43M -335K -241K -208K -195K -178K -23.05M -336K -2.31M -902K -11.63M -905K -886K -38.58M
Net Debt 804K 579K 499K 468K 427K 55.32M 807K 5.55M 2.16M 27.92M 2.17M 2.13M 92.59M 999K 719K 620K 581K 530K 68.74M 1M 6.89M 2.69M 34.7M 2.7M 2.64M 115M
Logo Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corporation is a Canadian ophthalmic drugs company. The Company is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The Company has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.
Employees
4,000
Date Price Change Volume
27/08/26 CA$0.0200 0.00% 3,000
  1. Stock Market
  2. Stocks
  3. GENX Stock